Global Large Volume Parenteral (LVP) Market Research Report 2021

Global Large Volume Parenteral (LVP) Market Research Report 2021

Table of Contents
1 Large Volume Parenteral (LVP) Market Overview
1.1 Product Overview and Scope of Large Volume Parenteral (LVP)
1.2 Large Volume Parenteral (LVP) Segment by Type
1.2.1 Global Large Volume Parenteral (LVP) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) Segment by Application
1.3.1 Large Volume Parenteral (LVP) Sales Comparison by Application: (2021-2027)
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenteral (LVP) Revenue 2016-2027
1.4.2 Global Large Volume Parenteral (LVP) Sales 2016-2027
1.4.3 Large Volume Parenteral (LVP) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Large Volume Parenteral (LVP) Market Competition by Manufacturers
2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites, Area Served, Product Type
2.5 Large Volume Parenteral (LVP) Market Competitive Situation and Trends
2.5.1 Large Volume Parenteral (LVP) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Large Volume Parenteral (LVP) Players Market Share by Revenue
2.5.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Large Volume Parenteral (LVP) Retrospective Market Scenario by Region
3.1 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.3.1 North America Large Volume Parenteral (LVP) Sales by Country
3.3.2 North America Large Volume Parenteral (LVP) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.4.1 Europe Large Volume Parenteral (LVP) Sales by Country
3.4.2 Europe Large Volume Parenteral (LVP) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Region
3.5.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Region
3.5.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.6.1 Latin America Large Volume Parenteral (LVP) Sales by Country
3.6.2 Latin America Large Volume Parenteral (LVP) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.7.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country
3.7.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Large Volume Parenteral (LVP) Historic Market Analysis by Type
4.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
4.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2016-2021)
4.3 Global Large Volume Parenteral (LVP) Price by Type (2016-2021)
5 Global Large Volume Parenteral (LVP) Historic Market Analysis by Application
5.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
5.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2016-2021)
5.3 Global Large Volume Parenteral (LVP) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Baxter Healthcare
6.1.1 Baxter Healthcare Corporation Information
6.1.2 Baxter Healthcare Description and Business Overview
6.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Baxter Healthcare Product Portfolio
6.1.5 Baxter Healthcare Recent Developments/Updates
6.2 Kelun Pharma
6.2.1 Kelun Pharma Corporation Information
6.2.2 Kelun Pharma Description and Business Overview
6.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Kelun Pharma Product Portfolio
6.2.5 Kelun Pharma Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 B. Braun Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Fresenius
6.4.1 Fresenius Corporation Information
6.4.2 Fresenius Description and Business Overview
6.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Fresenius Product Portfolio
6.4.5 Fresenius Recent Developments/Updates
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Corporation Information
6.5.2 Teva Pharmaceutical Industries Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Pharmaceutical Industries Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.6 Pfizer (Hospira)
6.6.1 Pfizer (Hospira) Corporation Information
6.6.2 Pfizer (Hospira) Description and Business Overview
6.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Pfizer (Hospira) Product Portfolio
6.6.5 Pfizer (Hospira) Recent Developments/Updates
6.7 Ostuka Pharmaceutical
6.6.1 Ostuka Pharmaceutical Corporation Information
6.6.2 Ostuka Pharmaceutical Description and Business Overview
6.6.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ostuka Pharmaceutical Product Portfolio
6.7.5 Ostuka Pharmaceutical Recent Developments/Updates
6.8 CR Double-Crane
6.8.1 CR Double-Crane Corporation Information
6.8.2 CR Double-Crane Description and Business Overview
6.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 CR Double-Crane Product Portfolio
6.8.5 CR Double-Crane Recent Developments/Updates
6.9 Pisa
6.9.1 Pisa Corporation Information
6.9.2 Pisa Description and Business Overview
6.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Pisa Product Portfolio
6.9.5 Pisa Recent Developments/Updates
6.10 Huaren
6.10.1 Huaren Corporation Information
6.10.2 Huaren Description and Business Overview
6.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Huaren Product Portfolio
6.10.5 Huaren Recent Developments/Updates
6.11 Patheon
6.11.1 Patheon Corporation Information
6.11.2 Patheon Large Volume Parenteral (LVP) Description and Business Overview
6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Patheon Product Portfolio
6.11.5 Patheon Recent Developments/Updates
6.12 Aspen Holdings
6.12.1 Aspen Holdings Corporation Information
6.12.2 Aspen Holdings Large Volume Parenteral (LVP) Description and Business Overview
6.12.3 Aspen Holdings Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Aspen Holdings Product Portfolio
6.12.5 Aspen Holdings Recent Developments/Updates
6.13 Beximco Pharma
6.13.1 Beximco Pharma Corporation Information
6.13.2 Beximco Pharma Large Volume Parenteral (LVP) Description and Business Overview
6.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Beximco Pharma Product Portfolio
6.13.5 Beximco Pharma Recent Developments/Updates
6.14 Cook Pharmica
6.14.1 Cook Pharmica Corporation Information
6.14.2 Cook Pharmica Large Volume Parenteral (LVP) Description and Business Overview
6.14.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Cook Pharmica Product Portfolio
6.14.5 Cook Pharmica Recent Developments/Updates
6.15 Albert David
6.15.1 Albert David Corporation Information
6.15.2 Albert David Large Volume Parenteral (LVP) Description and Business Overview
6.15.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Albert David Product Portfolio
6.15.5 Albert David Recent Developments/Updates
6.16 PSI Ltd
6.16.1 PSI Ltd Corporation Information
6.16.2 PSI Ltd Large Volume Parenteral (LVP) Description and Business Overview
6.16.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 PSI Ltd Product Portfolio
6.16.5 PSI Ltd Recent Developments/Updates
6.17 Ozon Pharmaceuticals
6.17.1 Ozon Pharmaceuticals Corporation Information
6.17.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Description and Business Overview
6.17.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Ozon Pharmaceuticals Product Portfolio
6.17.5 Ozon Pharmaceuticals Recent Developments/Updates
6.18 BAG Healthcare
6.18.1 BAG Healthcare Corporation Information
6.18.2 BAG Healthcare Large Volume Parenteral (LVP) Description and Business Overview
6.18.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.18.4 BAG Healthcare Product Portfolio
6.18.5 BAG Healthcare Recent Developments/Updates
6.19 BML Parenteral Drugs
6.19.1 BML Parenteral Drugs Corporation Information
6.19.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Description and Business Overview
6.19.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.19.4 BML Parenteral Drugs Product Portfolio
6.19.5 BML Parenteral Drugs Recent Developments/Updates
7 Large Volume Parenteral (LVP) Manufacturing Cost Analysis
7.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
7.4 Large Volume Parenteral (LVP) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Large Volume Parenteral (LVP) Distributors List
8.3 Large Volume Parenteral (LVP) Customers
9 Large Volume Parenteral (LVP) Market Dynamics
9.1 Large Volume Parenteral (LVP) Industry Trends
9.2 Large Volume Parenteral (LVP) Growth Drivers
9.3 Large Volume Parenteral (LVP) Market Challenges
9.4 Large Volume Parenteral (LVP) Market Restraints
10 Global Market Forecast
10.1 Large Volume Parenteral (LVP) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Type (2022-2027)
10.2 Large Volume Parenteral (LVP) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Application (2022-2027)
10.3 Large Volume Parenteral (LVP) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Large Volume Parenteral (LVP) Sales (M Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Large Volume Parenteral (LVP) Sales (M Units) Comparison by Application (2021-2027)
Table 3. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Large Volume Parenteral (LVP) Covered in This Study
Table 5. Global Large Volume Parenteral (LVP) Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Large Volume Parenteral (LVP) Sales Share by Manufacturers (2016-2021)
Table 7. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Large Volume Parenteral (LVP) Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites and Area Served
Table 11. Manufacturers Large Volume Parenteral (LVP) Product Type
Table 12. Global Large Volume Parenteral (LVP) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Volume Parenteral (LVP) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Large Volume Parenteral (LVP) Sales by Region (2016-2021) & (M Units)
Table 16. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
Table 17. Global Large Volume Parenteral (LVP) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 19. North America Large Volume Parenteral (LVP) Sales Market Share by Country (2016-2021)
Table 20. North America Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Large Volume Parenteral (LVP) Revenue Market Share by Country (2016-2021)
Table 22. Europe Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 23. Europe Large Volume Parenteral (LVP) Sales Market Share by Country (2016-2021)
Table 24. Europe Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country (2016-2021)
Table 32. Latin America Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Country (2016-2021)
Table 38. Global Large Volume Parenteral (LVP) Sales (M Units) by Type (2016-2021)
Table 39. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 40. Global Large Volume Parenteral (LVP) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Large Volume Parenteral (LVP) Revenue Share by Type (2016-2021)
Table 42. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Type (2016-2021)
Table 43. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2016-2021)
Table 44. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 45. Global Large Volume Parenteral (LVP) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Large Volume Parenteral (LVP) Revenue Share by Application (2016-2021)
Table 47. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Application (2016-2021)
Table 48. Baxter Healthcare Corporation Information
Table 49. Baxter Healthcare Description and Business Overview
Table 50. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Baxter Healthcare Large Volume Parenteral (LVP) Product
Table 52. Baxter Healthcare Recent Developments/Updates
Table 53. Kelun Pharma Corporation Information
Table 54. Kelun Pharma Description and Business Overview
Table 55. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Kelun Pharma Large Volume Parenteral (LVP) Product
Table 57. Kelun Pharma Recent Developments/Updates
Table 58. B. Braun Corporation Information
Table 59. B. Braun Description and Business Overview
Table 60. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. B. Braun Large Volume Parenteral (LVP) Product
Table 62. B. Braun Recent Developments/Updates
Table 63. Fresenius Corporation Information
Table 64. Fresenius Description and Business Overview
Table 65. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Fresenius Large Volume Parenteral (LVP) Product
Table 67. Fresenius Recent Developments/Updates
Table 68. Teva Pharmaceutical Industries Corporation Information
Table 69. Teva Pharmaceutical Industries Description and Business Overview
Table 70. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product
Table 72. Teva Pharmaceutical Industries Recent Developments/Updates
Table 73. Pfizer (Hospira) Corporation Information
Table 74. Pfizer (Hospira) Description and Business Overview
Table 75. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Pfizer (Hospira) Large Volume Parenteral (LVP) Product
Table 77. Pfizer (Hospira) Recent Developments/Updates
Table 78. Ostuka Pharmaceutical Corporation Information
Table 79. Ostuka Pharmaceutical Description and Business Overview
Table 80. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product
Table 82. Ostuka Pharmaceutical Recent Developments/Updates
Table 83. CR Double-Crane Corporation Information
Table 84. CR Double-Crane Description and Business Overview
Table 85. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. CR Double-Crane Large Volume Parenteral (LVP) Product
Table 87. CR Double-Crane Recent Developments/Updates
Table 88. Pisa Corporation Information
Table 89. Pisa Description and Business Overview
Table 90. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Pisa Large Volume Parenteral (LVP) Product
Table 92. Pisa Recent Developments/Updates
Table 93. Huaren Corporation Information
Table 94. Huaren Description and Business Overview
Table 95. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Huaren Large Volume Parenteral (LVP) Product
Table 97. Huaren Recent Developments/Updates
Table 98. Patheon Corporation Information
Table 99. Patheon Description and Business Overview
Table 100. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Patheon Large Volume Parenteral (LVP) Product
Table 102. Patheon Recent Developments/Updates
Table 103. Aspen Holdings Corporation Information
Table 104. Aspen Holdings Description and Business Overview
Table 105. Aspen Holdings Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Aspen Holdings Large Volume Parenteral (LVP) Product
Table 107. Aspen Holdings Recent Developments/Updates
Table 108. Beximco Pharma Corporation Information
Table 109. Beximco Pharma Description and Business Overview
Table 110. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Beximco Pharma Large Volume Parenteral (LVP) Product
Table 112. Beximco Pharma Recent Developments/Updates
Table 113. Cook Pharmica Corporation Information
Table 114. Cook Pharmica Description and Business Overview
Table 115. Cook Pharmica Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Cook Pharmica Large Volume Parenteral (LVP) Product
Table 117. Cook Pharmica Recent Developments/Updates
Table 118. Albert David Corporation Information
Table 119. Albert David Description and Business Overview
Table 120. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Albert David Large Volume Parenteral (LVP) Product
Table 122. Albert David Recent Developments/Updates
Table 123. PSI Ltd Corporation Information
Table 124. PSI Ltd Description and Business Overview
Table 125. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. PSI Ltd Large Volume Parenteral (LVP) Product
Table 127. PSI Ltd Recent Developments/Updates
Table 128. Ozon Pharmaceuticals Corporation Information
Table 129. Ozon Pharmaceuticals Description and Business Overview
Table 130. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product
Table 132. Ozon Pharmaceuticals Recent Developments/Updates
Table 133. BAG Healthcare Corporation Information
Table 134. BAG Healthcare Description and Business Overview
Table 135. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. BAG Healthcare Large Volume Parenteral (LVP) Product
Table 137. BAG Healthcare Recent Developments/Updates
Table 138. BML Parenteral Drugs Corporation Information
Table 139. BML Parenteral Drugs Description and Business Overview
Table 140. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. BML Parenteral Drugs Large Volume Parenteral (LVP) Product
Table 142. BML Parenteral Drugs Recent Developments/Updates
Table 143. Production Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Large Volume Parenteral (LVP) Distributors List
Table 146. Large Volume Parenteral (LVP) Customers List
Table 147. Large Volume Parenteral (LVP) Market Trends
Table 148. Large Volume Parenteral (LVP) Growth Drivers
Table 149. Large Volume Parenteral (LVP) Market Restraints
Table 150. Global Large Volume Parenteral (LVP) Sales Forecast by Type (2022-2027) & (M Units)
Table 151. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Type (2022-2027)
Table 152. Global Large Volume Parenteral (LVP) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 153. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Type (2022-2027)
Table 154. Global Large Volume Parenteral (LVP) Sales Forecast by Application (2022-2027) & (M Units)
Table 155. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Application (2022-2027)
Table 156. Global Large Volume Parenteral (LVP) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 157. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Application (2022-2027)
Table 158. Global Large Volume Parenteral (LVP) Sales Forecast by Region (2022-2027) & (M Units)
Table 159. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Region (2022-2027)
Table 160. Global Large Volume Parenteral (LVP) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 161. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Region (2022-2027)
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Large Volume Parenteral (LVP)
Figure 2. Global Large Volume Parenteral (LVP) Market Share by Type in 2020 & 2027
Figure 3. Soft Bag LVP Product Picture
Figure 4. Plastic Bottle LVP Product Picture
Figure 5. Glass Bottle LVP Product Picture
Figure 6. Global Large Volume Parenteral (LVP) Market Share by Application in 2020 & 2027
Figure 7. Basic Infusion
Figure 8. Therapeutic Infusion
Figure 9. Nutritious Infusion
Figure 10. Global Large Volume Parenteral (LVP) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Large Volume Parenteral (LVP) Market Size 2016-2027 (US$ Million)
Figure 12. Global Large Volume Parenteral (LVP) Sales 2016-2027 (M Units)
Figure 13. Global Large Volume Parenteral (LVP) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Large Volume Parenteral (LVP) Sales Share by Manufacturers in 2020
Figure 15. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Large Volume Parenteral (LVP) Players: Market Share by Revenue in 2020
Figure 17. Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
Figure 19. Global Large Volume Parenteral (LVP) Sales Market Share by Region in 2020
Figure 20. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2016-2021)
Figure 21. Global Large Volume Parenteral (LVP) Revenue Market Share by Region in 2020
Figure 22. U.S. Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Large Volume Parenteral (LVP) by Type (2016-2021)
Figure 47. Sales Market Share of Large Volume Parenteral (LVP) by Application (2016-2021)
Figure 48. Sales Market Share of Large Volume Parenteral (LVP) by Application in 2020
Figure 49. Revenue Share of Large Volume Parenteral (LVP) by Application (2016-2021)
Figure 50. Revenue Share of Large Volume Parenteral (LVP) by Application in 2020
Figure 51. Manufacturing Cost Structure of Large Volume Parenteral (LVP)
Figure 52. Manufacturing Process Analysis of Large Volume Parenteral (LVP)
Figure 53. Large Volume Parenteral (LVP) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs